Annual ROE
-156.66%
-78.55%-100.56%
31 December 2023
Summary:
Alaunos Therapeutics annual return on equity is currently -156.66%, with the most recent change of -78.55% (-100.56%) on 31 December 2023. During the last 3 years, it has fallen by -83.62% (-114.49%). TCRT annual ROE is now -103.97% below its all-time high of 3941.30%, reached on 31 December 2004.TCRT ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-267.77%
-78.08%-41.16%
30 September 2024
Summary:
Alaunos Therapeutics quarterly return on equity is currently -267.77%, with the most recent change of -78.08% (-41.16%) on 30 September 2024. Over the past year, it has dropped by -133.47% (-99.38%). TCRT quarterly ROE is now -101.50% below its all-time high of 17.83 thousand%, reached on 30 June 2005.TCRT Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TCRT ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -100.6% | -99.4% |
| 3 y3 years | -114.5% | -217.2% |
| 5 y5 years | -95.8% | -55.2% |
TCRT ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -114.5% | at low | -229.3% | at low |
| 5 y | 5 years | -114.5% | at low | -406.4% | at low |
| alltime | all time | -104.0% | +41.9% | -101.5% | +48.1% |
Alaunos Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -267.77%(+41.2%) |
| June 2024 | - | -189.69%(+7.9%) |
| Mar 2024 | - | -175.77%(+10.0%) |
| Dec 2023 | -156.66%(+100.6%) | -159.84%(+19.0%) |
| Sept 2023 | - | -134.30%(+18.1%) |
| June 2023 | - | -113.67%(+13.4%) |
| Mar 2023 | - | -100.25%(+15.9%) |
| Dec 2022 | -78.11%(-9.7%) | -86.53%(+6.4%) |
| Sept 2022 | - | -81.32%(-8.8%) |
| June 2022 | - | -89.12%(-1.6%) |
| Mar 2022 | - | -90.57%(+2.3%) |
| Dec 2021 | -86.52%(+18.5%) | -88.55%(+4.9%) |
| Sept 2021 | - | -84.41%(+21.1%) |
| June 2021 | - | -69.71%(+20.3%) |
| Mar 2021 | - | -57.94%(+2.5%) |
| Dec 2020 | -73.04%(-44.0%) | -56.51%(+6.9%) |
| Sept 2020 | - | -52.88%(-49.3%) |
| June 2020 | - | -104.33%(-11.9%) |
| Mar 2020 | - | -118.47%(-14.9%) |
| Dec 2019 | -130.47%(+63.0%) | -139.27%(-19.3%) |
| Sept 2019 | - | -172.53%(+56.5%) |
| June 2019 | - | -110.22%(-10.6%) |
| Mar 2019 | - | -123.32%(-17.4%) |
| Dec 2018 | -80.03%(-29.9%) | -149.33%(-16.0%) |
| Sept 2018 | - | -177.85%(+43.2%) |
| June 2018 | - | -124.20%(+7.2%) |
| Mar 2018 | - | -115.81%(+10.4%) |
| Dec 2017 | -114.11%(-53.3%) | -104.88%(+8.0%) |
| Sept 2017 | - | -97.10%(-39.2%) |
| June 2017 | - | -159.65%(-68.6%) |
| Mar 2017 | - | -509.00%(+34.6%) |
| Dec 2016 | -244.17%(+23.2%) | -378.06%(+22.3%) |
| Sept 2016 | - | -309.25%(+14.9%) |
| June 2016 | - | -269.10%(+389.5%) |
| Mar 2016 | - | -54.97%(-59.2%) |
| Dec 2015 | -198.15%(+159.5%) | -134.60%(-12.1%) |
| Sept 2015 | - | -153.10%(-4.7%) |
| June 2015 | - | -160.64%(-13.4%) |
| Mar 2015 | - | -185.49%(+132.5%) |
| Dec 2014 | -76.37%(-34.6%) | -79.79%(-11.0%) |
| Sept 2014 | - | -89.63%(-33.5%) |
| June 2014 | - | -134.74%(-24.2%) |
| Mar 2014 | - | -177.73%(-1.2%) |
| Dec 2013 | -116.75%(-27.1%) | -179.94%(-22.8%) |
| Sept 2013 | - | -232.96%(+40.8%) |
| June 2013 | - | -165.48%(+24.9%) |
| Mar 2013 | - | -132.51%(-2.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | -160.15%(+28.3%) | -136.39%(+33.7%) |
| Sept 2012 | - | -101.98%(+35.6%) |
| June 2012 | - | -75.18%(+28.1%) |
| Mar 2012 | - | -58.69%(-35.1%) |
| Dec 2011 | -124.86%(+12.1%) | -90.50%(-6.3%) |
| Sept 2011 | - | -96.59%(-23.1%) |
| June 2011 | - | -125.68%(+2.7%) |
| Mar 2011 | - | -122.33%(+25.0%) |
| Dec 2010 | -111.39%(+153.7%) | -97.83%(+38.3%) |
| Sept 2010 | - | -70.74%(+34.2%) |
| June 2010 | - | -52.73%(-76.6%) |
| Mar 2010 | - | -224.90%(+159.8%) |
| Dec 2009 | -43.91%(-67.7%) | -86.56%(-64.4%) |
| Sept 2009 | - | -242.82%(+20.8%) |
| June 2009 | - | -200.96%(+20.8%) |
| Mar 2009 | - | -166.34%(+14.2%) |
| Dec 2008 | -135.98%(+45.4%) | -145.69%(+20.7%) |
| Sept 2008 | - | -120.66%(+21.0%) |
| June 2008 | - | -99.72%(+22.7%) |
| Mar 2008 | - | -81.28%(+16.1%) |
| Dec 2007 | -93.52%(-11.7%) | -70.01%(+8.5%) |
| Sept 2007 | - | -64.52%(+16.9%) |
| June 2007 | - | -55.17%(-16.6%) |
| Mar 2007 | - | -66.18%(-22.1%) |
| Dec 2006 | -105.87%(-60.7%) | -84.96%(+3.3%) |
| Sept 2006 | - | -82.27%(-33.1%) |
| June 2006 | - | -123.01%(-50.6%) |
| Mar 2006 | - | -249.14%(-13.1%) |
| Dec 2005 | -269.69%(-106.8%) | -286.73%(-44.5%) |
| Sept 2005 | - | -516.44%(-102.9%) |
| June 2005 | - | 17.83 K%(+35.6%) |
| Mar 2005 | - | 13.15 K%(+59.8%) |
| Dec 2004 | 3941.30%(+532.7%) | 8227.13%(+3.8%) |
| Sept 2004 | - | 7927.89%(+857.6%) |
| June 2004 | - | 827.86%(+8.1%) |
| Mar 2004 | - | 765.81%(-12.8%) |
| Dec 2003 | 622.96%(+170.1%) | 878.46%(+295.7%) |
| Sept 2003 | - | 222.02%(-8.0%) |
| June 2003 | - | 241.28%(-26.3%) |
| Mar 2003 | - | 327.57%(-17.5%) |
| Dec 2002 | 230.64%(-55.8%) | 397.02%(-47.4%) |
| Sept 2002 | - | 754.47%(-8.5%) |
| June 2002 | - | 824.78%(-10.9%) |
| Mar 2002 | - | 926.10%(+11.1%) |
| Dec 2001 | 521.58% | 833.33%(+58.4%) |
| Sept 2001 | - | 526.23%(-59.3%) |
| June 2001 | - | 1292.86% |
FAQ
- What is Alaunos Therapeutics annual return on equity?
- What is the all time high annual ROE for Alaunos Therapeutics?
- What is Alaunos Therapeutics annual ROE year-on-year change?
- What is Alaunos Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Alaunos Therapeutics?
- What is Alaunos Therapeutics quarterly ROE year-on-year change?
What is Alaunos Therapeutics annual return on equity?
The current annual ROE of TCRT is -156.66%
What is the all time high annual ROE for Alaunos Therapeutics?
Alaunos Therapeutics all-time high annual return on equity is 3941.30%
What is Alaunos Therapeutics annual ROE year-on-year change?
Over the past year, TCRT annual return on equity has changed by -78.55% (-100.56%)
What is Alaunos Therapeutics quarterly return on equity?
The current quarterly ROE of TCRT is -267.77%
What is the all time high quarterly ROE for Alaunos Therapeutics?
Alaunos Therapeutics all-time high quarterly return on equity is 17.83 K%
What is Alaunos Therapeutics quarterly ROE year-on-year change?
Over the past year, TCRT quarterly return on equity has changed by -133.47% (-99.38%)